Correlation Between Visual Reading and DOlab Software Quantitative Analysis of DaT-SPECT Images
A legfontosabb adatok
- Ki végzi
- Dorian Technologies S.r.l.
- Hol
- Olaszország2 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 120 fő, tervezett
- Kezdés
- 2026. okt. 13.
- Várható befejezés
- 2027. márc.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- DOlab software - DaT-SPECT workflow
- Visual interpretation (comparator)
- A regiszteradat frissítve
- 2026. november 17.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 12 feltétel megnézéseKevesebb
Ki vehet részt
- Age 18 years or older
- Referred for evaluation of nigrostriatal dopaminergic dysfunction to one of the participating centers between January 2015 and May 2025
- Informed consent for data collection, or documentation that all reasonable efforts to obtain consent were made (Italian Privacy Code, art. 110)
- 123I-ioflupane SPECT images that:
- were acquired according to the PPMI imaging protocol
- have a field of view covering the entire head, from the superior cortical regions to the lower cerebellum
- followed the radiotracer manufacturer's acquisition timing and methods
- were attenuation-corrected according to local standard procedures
Ki nem vehet részt
- Use of drugs or substances that may significantly affect DaT binding (e.g., cocaine, amphetamines, CNS stimulants, opioid derivatives, antidepressants, adrenergic agonists, anticholinergics, anesthetics) without a washout of at least five biological half-lives before DaT-SPECT, per the EANM/SNMMI guidelines
- Age under 18 years
- DaT-SPECT performed outside the January 2015 - May 2025 period
- Images not meeting the acquisition and quality specifications listed above
Ez a vizsgálat jelenleg itt érhető el: Olaszország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this study is to find out whether the quantitative results of DOlab software (DaT-SPECT workflow) agree with the visual reading of brain scans performed by nuclear medicine physicians. The scans are 123I-ioflupane DaT-SPECT images of adults who were evaluated for dopamine transporter dysfunction, a condition seen in Parkinson's disease, other parkinsonian syndromes and dementia with Lewy bodies.
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
* Do the visual scores given by expert readers (0 = normal to 3 = marked abnormality) correlate with the values calculated by the software? * Does using the software report change or refine the readers' classification compared with visual reading alone? * How usable do readers find the software?
The study uses existing scans of 120 patients collected between January 2015 and May 2025 at two Italian hospitals. No new tests or treatments are given to participants, and the software results are not used for their clinical care.
A vizsgálat csoportja
- Adults referred for DaT-SPECT
Adults referred for evaluation of nigrostriatal dopaminergic dysfunction at the two participating centers between January 2015 and May 2025, whose existing 123I-ioflupane DaT-SPECT scans were selected retrospectively (30 per visual grade 0-3, 15 per grade per center). Each scan is read visually by four blinded readers, analyzed by DOlab software, and then re-read with the software report.
Kezelés: DOlab software - DaT-SPECT workflow és Visual interpretation (comparator)
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Pre-market Clinical Investigation to Evaluate the Correlation Between Visual Interpretation and Quantitative Analysis Performed by DOlab Software - DaT-SPECT Workflow for the Identification of Neurological Disorders Related to Dopamine Transporter Dysfunction
- A regiszteradat frissítve
- 2026. november 17.